120 related articles for article (PubMed ID: 2104768)
21. Investigation of alternative mechanisms of collagen-induced platelet activation by using monoclonal antibodies to glycoprotein IIb-IIIa and fibrinogen.
Connellan JM; Thurlow PJ; Barlow B; Lowe M; McKenzie IF
Thromb Haemost; 1986 Apr; 55(2):153-7. PubMed ID: 2940722
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of the diacylglycerol kinase inhibitor R59022 on thrombin versus collagen-induced human platelet secretion.
Joseph S; Krishnamurthi S; Kakkar VV
Biochim Biophys Acta; 1988 Apr; 969(1):9-17. PubMed ID: 2832002
[TBL] [Abstract][Full Text] [Related]
23. Does intracellular histamine mediate mast cell histamine release?
Brandes LJ; Sukhu B; Bogdanovic RP
Biochem Biophys Res Commun; 1990 Mar; 167(2):665-72. PubMed ID: 1690990
[TBL] [Abstract][Full Text] [Related]
24. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
Lewis GP; Watts IS
Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
[TBL] [Abstract][Full Text] [Related]
26. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
27. Protease and cyclooxygenase inhibitors synergistically prevent activation of human platelets.
Ruggiero M; Lapetina EG
Proc Natl Acad Sci U S A; 1986 May; 83(10):3456-9. PubMed ID: 3458190
[TBL] [Abstract][Full Text] [Related]
28. 3,3',5'-Triiodothyronine inhibits collagen-induced human platelet aggregation.
Masaki H; Nishikawa M; Urakami M; Yoshimura M; Toyoda N; Mori Y; Yoshikawa N; Inada M
J Clin Endocrinol Metab; 1992 Sep; 75(3):721-5. PubMed ID: 1517361
[TBL] [Abstract][Full Text] [Related]
29. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of platelet aggregation and thromboxane production by low concentrations of aspirin in vitro.
Sils D; Rodgers SE; Lloyd JV; Wilson KM; Siebert DM; Bochner F
Clin Sci (Lond); 1988 May; 74(5):491-7. PubMed ID: 3370916
[TBL] [Abstract][Full Text] [Related]
31. Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro.
Jakubowski JA; Vaillancourt R; Deykin D
Arteriosclerosis; 1988; 8(4):436-41. PubMed ID: 2840054
[TBL] [Abstract][Full Text] [Related]
32. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets.
McNicol A; Jackson EC
Biochem Pharmacol; 2003 Apr; 65(8):1243-50. PubMed ID: 12694865
[TBL] [Abstract][Full Text] [Related]
34. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
Salvemini D; de Nucci G; Vane JR
Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
[TBL] [Abstract][Full Text] [Related]
35. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
36. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver.
Brandes LJ; Davie JR; Paraskevas F; Sukhu B; Bogdanovic RP; LaBella FS
Agents Actions Suppl; 1991; 33():325-42. PubMed ID: 2053513
[TBL] [Abstract][Full Text] [Related]
37. Platelet function in Watanabe heritable hyperlipidemic rabbits. Decreased sensitivity to thromboxane A2.
Gross PL; Rand ML; Barrow DV; Packham MA
Arterioscler Thromb; 1991; 11(3):610-6. PubMed ID: 2029501
[TBL] [Abstract][Full Text] [Related]
38. Control of platelet protein kinase C activation by cyclic AMP.
Kroll MH; Zavoico GB; Schafer AI
Biochim Biophys Acta; 1988 Jun; 970(1):61-7. PubMed ID: 2835990
[TBL] [Abstract][Full Text] [Related]
39. Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by release or by thromboxane synthesis.
Heyns Adu P; Eldor A; Yarom R; Marx G
Blood; 1985 Jul; 66(1):213-9. PubMed ID: 2988668
[TBL] [Abstract][Full Text] [Related]
40. Vanadate activates platelets by enhancing arachidonic acid release.
McNicol A; Robertson C; Gerrard JM
Blood; 1993 May; 81(9):2329-38. PubMed ID: 8481513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
